| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
• Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) stock increased by 34.1% to $2.75 during Tuesday's pre-market session.
• Onconova Therapeutics, Inc. (NASDAQ:ONTX) stock moved upwards by 8.5% to $0.65.
• MorphoSys, Inc. (NASDAQ:MOR) stock increased by 3.5% to $31.47. According to the most recent rating by Guggenheim, on November 20, the current rating is at Buy.
• Valeritas Holdings, Inc. (NASDAQ:VLRX) stock plummeted 11.4% to $0.32 during Tuesday's pre-market session. According to the most recent rating by Oppenheimer, on December 23, the current rating is at Perform.
• Co-Diagnostics, Inc. (NASDAQ:CODX) stock decreased by 10.9% to $3.53.
• Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares plummeted 6.4% to $0.80. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $2.00.
• vTv Therapeutics, Inc. (NASDAQ:VTVT) shares declined 6.2% to $3.00. The most recent rating by H.C. Wainwright, on February 10, is at Buy, with a price target of $6.00.
• Phio Pharmaceuticals, Inc. (NASDAQ:PHIO) stock fell 4.0% to $6.40.
